Lv11
30 积分 2025-05-28 加入
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
3小时前
已完结
SIRT1: a promising therapeutic target in type 2 diabetes mellitus
23天前
已完结
Neuroprotective effects of saxagliptin against radiation-induced cognitive impairment: Insights on Akt/CREB/SIRT1/BDNF signaling pathway
24天前
已关闭
Bioactive peptides PIISVYWK and FSVVPSPK improve glucose homeostasis by targeting DPP-IV and glucose transport in type 2 diabetic mice
24天前
已完结
Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase‐4 inhibitor plus low‐dose metformin: A multicenter, prospective, randomized, open‐label, parallel‐group comparison study (MEGMI study)
24天前
已完结
Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase‐4 inhibitor plus low‐dose metformin: A multicenter, prospective, randomized, open‐label, parallel‐group comparison study (MEGMI study)
27天前
已关闭
DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
29天前
已完结
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases
29天前
已完结
DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
29天前
已关闭
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases
30天前
已关闭
皖公网安备34019202002308
